Evidence map›Paper›PMID 40057769›Full record

ArticleJournal of neuroinflammation2025

Neuroinflammation causes mitral cell dysfunction and olfactory impairment in a multiple sclerosis model.

Charlotte Schubert, Kristina Schulz, Jana K Sonner, Alexandros Hadjilaou, Anna-Lena Seemann, Janine Gierke, Vanessa Vieira, Nina Meurs, Marcel S Woo, Christian Lohr and 3 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Glial pathology networks reveal early olfactory vulnerability in post mortem human Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Charlotte SchubertInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-2967-4290
Kristina SchulzInstitute of Cell and Systems Biology of Animals, University of Hamburg, Hamburg, Germany.
Jana K SonnerInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-4700-272X
Alexandros HadjilaouInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-2443-9611
Anna-Lena SeemannInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Janine GierkeInstitute of Cell and Systems Biology of Animals, University of Hamburg, Hamburg, Germany.
Vanessa VieiraInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-0205-9669
Nina MeursInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0001-5366-0123
Marcel S WooInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-1306-2708
Christian LohrInstitute of Cell and Systems Biology of Animals, University of Hamburg, Hamburg, Germany.ORCID http://orcid.org/0000-0001-6518-6422
Fabio MorelliniResearch Group Behavioral Biology, Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-5185-3850
Daniela Hirnet *Institute of Cell and Systems Biology of Animals, University of Hamburg, Hamburg, Germany.ORCID http://orcid.org/0009-0004-0566-4604
Manuel A Friese *Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. manuel.friese@zmnh.uni-hamburg.de.ORCID http://orcid.org/0000-0001-6380-2420

Funding

Deutsche Forschungsgemeinschaft SFB 1328 project A16
6 · The paper itself

Abstract

backgroundOlfactory dysfunction is an underestimated symptom in multiple sclerosis (MS). Here, we examined the pathogenic mechanisms underlying inflammation-induced dysfunction of the olfactory bulb using the animal model of MS, experimental autoimmune encephalomyelitis (EAE).

resultsReduced olfactory function in EAE was associated with the degeneration of short-axon neurons, immature neurons, and both mitral and tufted cells, along with their synaptic interactions and axonal repertoire. To dissect the mechanisms underlying the susceptibility of mitral cells, the main projection neurons of the olfactory bulb, we profiled their responses to neuroinflammation by single-nucleus RNA sequencing followed by functional validation. Neuroinflammation resulted in the induction of potassium channel transcripts in mitral cells, which was reflected in increased halothane-induced outward currents of these cells, likely contributing to the impaired olfaction in EAE animals.

conclusionThis study reveals the crucial role of mitral cells and their potassium channel activity in the olfactory bulb during EAE, thereby enhancing our understanding of neuroinflammation-induced neurodegeneration in MS.

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisNeuroinflammatory DiseasesOlfaction DisordersOlfactory BulbAnimalsDisease Models, AnimalFemaleMiceMice, Inbred C57BLExperimental autoimmune encephalomyelitisMitral cellsMonoatomic ion channel activityMultiple sclerosisNeuroinflammationOlfactory bulbPotassium channelsSingle-nucleus RNA sequencingTASK-2

Identifiers

PMID40057769
PMCPMC11889885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.